Suppr超能文献

共抑制分子在脓毒症免疫功能障碍中作用的研究进展

[Study progress of role of co-suppressor molecules in sepsis immune dysfunction].

作者信息

Gao Jinghua, Liu Zheying, Liu Zhifeng

机构信息

The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, Guangdong, China.

Department of Critical Care Medicine, General Hospital of Southern Theatre Command of PLA, Guangzhou 510010, Guangdong, China. Corresponding author: Liu Zhifeng, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jan;32(1):121-125. doi: 10.3760/cma.j.cn121430-20190916-00023.

Abstract

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. The pathophysiology core issue is that the body initiates a severe inflammatory reaction in response to the invasion of pathogenic microorganisms at the initial stage of disease. Subsequently, the body begins to fight inflammation in order to balance immunity status and eventually induces the immune paralysis or immunosuppressive state characterized by exhaustion of immune cell. Both in innate immunity and in acquired immunity, some co-suppressor molecules on the surface of immune cells play important roles in immunosuppression, such as, programmed death receptor-1 (PD-1), T cell immunoglobulin and mucin-containing protein-3 (TIM-3), cytotoxic T lymphocyte associated antigen-4 (CTLA-4), natural killer cell receptor 2B4 (CD244), B and T lymphocyte attenuator (BTLA) and NKG2A (CD94), et al. Blocking the interaction between these co-suppressor molecules and their ligands can significantly reverse the immunosuppressive state in septic animal models or patients. In order to provide a reference for the monitoring and treatment of sepsis immune dysfunction, this article mainly summarizes the new findings on the role of those co-suppressor molecules in sepsis immune dysfunction in recent years.

摘要

脓毒症被定义为由宿主对感染的失调反应引起的危及生命的器官功能障碍。病理生理学的核心问题是,在疾病初期,机体对致病微生物的入侵会引发严重的炎症反应。随后,机体开始对抗炎症,以平衡免疫状态,最终导致以免疫细胞耗竭为特征的免疫麻痹或免疫抑制状态。在固有免疫和获得性免疫中,免疫细胞表面的一些共抑制分子在免疫抑制中发挥重要作用,如程序性死亡受体-1(PD-1)、T细胞免疫球蛋白和含粘蛋白蛋白-3(TIM-3)、细胞毒性T淋巴细胞相关抗原-4(CTLA-4)、自然杀伤细胞受体2B4(CD244)、B和T淋巴细胞衰减器(BTLA)以及NKG2A(CD94)等。阻断这些共抑制分子与其配体之间的相互作用可显著逆转脓毒症动物模型或患者的免疫抑制状态。为了为脓毒症免疫功能障碍的监测和治疗提供参考,本文主要总结了近年来这些共抑制分子在脓毒症免疫功能障碍中作用的新发现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验